Carey P. Hendrickson Sells 516 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

U.S. Physical Therapy Stock Down 0.2 %

USPH stock opened at $96.27 on Wednesday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average price of $88.54 and a two-hundred day moving average price of $90.03. The company has a market cap of $1.45 billion, a price-to-earnings ratio of 102.41, a P/E/G ratio of 4.34 and a beta of 1.46. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were paid a $0.44 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.83%. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on USPH shares. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Canada Pension Plan Investment Board acquired a new position in U.S. Physical Therapy during the second quarter worth approximately $28,000. Innealta Capital LLC bought a new stake in U.S. Physical Therapy in the second quarter valued at approximately $30,000. Quest Partners LLC raised its stake in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the period. Quarry LP raised its stake in U.S. Physical Therapy by 1,291.9% in the second quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after buying an additional 478 shares during the period. Finally, Ridgewood Investments LLC bought a new stake in U.S. Physical Therapy in the second quarter valued at approximately $51,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.